Clinical & Experimental Cardiology
Open Access

Myocardial Infarction as a Metabolic Catastrophe inside Cardiac Cells

Chris Galey^{* *}Correspondence: Chris Galey, Department of Cardiovascular Medicine, Johns Hopkins University, Baltimore, USA, Email:

Author info »

Description

Myocardial infarction is traditionally described as the consequence of interrupted coronary blood flow leading to irreversible damage of heart muscle. While this vascular explanation is accurate, it only captures part of the pathological reality. At its core, myocardial infarction represents a profound metabolic catastrophe within cardiac cells, triggered by abrupt deprivation of oxygen and nutrients. The cardiomyocyte, a cell uniquely dependent on continuous energy production, rapidly descends into metabolic failure when ischemia occurs. Understanding myocardial infarction from this intracellular metabolic perspective reveals the mechanisms that drive cell death, tissue necrosis, and long-term cardiac dysfunction. Cardiac muscle cells are among the most metabolically active cells in the human body. Under normal conditions, cardiomyocytes generate vast quantities of adenosine triphosphate through oxidative phosphorylation in mitochondria. Fatty acids serve as the primary fuel source, supplemented by glucose, lactate, and ketone bodies. This tightly regulated metabolic flexibility allows the heart to meet constant mechanical demands. However, this reliance on aerobic metabolism also renders cardiac cells exceptionally vulnerable to interruptions in oxygen supply.

When coronary artery occlusion occurs, oxygen delivery to downstream myocardium drops precipitously. Within seconds, oxidative phosphorylation slows, and adenosine triphosphate (ATP) production declines. The heart attempts to compensate by shifting toward anaerobic glycolysis, but this pathway is inefficient and unsustainable. Anaerobic metabolism generates only a fraction of the ATP required for normal contractile function and produces lactate as a byproduct. Accumulation of lactic acid leads to intracellular acidosis, which disrupts enzymatic activity and alters protein structure. As ATP levels fall, energy-dependent cellular processes begin to fail. One of the earliest consequences is impairment of ion pumps embedded in the sarcolemma and sarcoplasmic reticulum. The sodium-potassium ATPase, essential for maintaining membrane potential, becomes dysfunctional, resulting in intracellular sodium accumulation. Simultaneously, calcium ATPases fail to regulate calcium homeostasis, leading to calcium overload within the cytosol and mitochondria. Elevated intracellular calcium activates proteases, phospholipases, and endonucleases that degrade essential cellular components.

Mitochondria lie at the center of this metabolic catastrophe. During ischemia, reduced oxygen availability halts electron transport, causing electrons to accumulate within the respiratory chain. This state primes mitochondria for excessive reactive oxygen species generation, particularly upon reperfusion. The mitochondrial membrane potential collapses, and permeability transition pores open, allowing solutes to enter the mitochondrial matrix. This event leads to mitochondrial swelling, rupture, and irreversible loss of ATP-generating capacity. Once mitochondrial integrity is compromised, cardiomyocyte survival becomes unlikely. The metabolic crisis is further exacerbated by substrate imbalance. Ischemia reduces fatty acid oxidation, yet circulating fatty acids may remain elevated, particularly in stress states. Accumulation of fatty acid intermediates and incomplete oxidation products exerts toxic effects on cell membranes and mitochondria. Glucose uptake may increase due to stress signaling, but impaired glycolytic flux and acidosis limit its utility. Thus, the cell is surrounded by fuel but incapable of effectively using it.

Oxidative stress plays a critical role in amplifying metabolic injury. Even during ischemia, small amounts of reactive oxygen species are generated from dysfunctional mitochondria. Upon reperfusion, oxygen reintroduction paradoxically intensifies oxidative damage. Reactive oxygen species attack lipids, proteins, and nucleic acids, further destabilizing membranes and enzymes. Antioxidant defenses are overwhelmed due to depleted NADPH and reduced glutathione availability, both consequences of metabolic dysfunction. Cell death pathways activated during myocardial infarction reflect the metabolic state of the cardiomyocyte. Severe and prolonged ATP depletion favors necrosis, characterized by membrane rupture and inflammatory response. In areas with partial energy preservation, apoptosis may occur, mediated by mitochondrial cytochrome c release and caspase activation. More recently, regulated necrosis pathways such as necroptosis and ferroptosis have been implicated, both tightly linked to metabolic disturbances involving lipid peroxidation and iron handling.

The metabolic catastrophe within individual cardiomyocytes does not occur in isolation. Gap junction dysfunction disrupts electrical and metabolic communication between neighboring cells, propagating injury across the myocardium. Endothelial cells and fibroblasts within the ischemic zone also experience metabolic stress, contributing to microvascular obstruction and impaired tissue repair. The combined effect is expansion of the infarcted area beyond the initial zone of ischemia. Following infarction, surviving cardiomyocytes undergo metabolic reprogramming. There is a shift toward increased glucose utilization and reduced fatty acid oxidation, resembling a fetal metabolic phenotype. While initially adaptive, this altered metabolism may contribute to long-term inefficiency and heart failure. Scar tissue replaces necrotic myocardium, permanently reducing the heart’s contractile and metabolic capacity.

The metabolic catastrophe within individual cardiomyocytes does not occur in isolation. Gap junction dysfunction disrupts electrical and metabolic communication between neighboring cells, propagating injury across the myocardium. Endothelial cells and fibroblasts within the ischemic zone also experience metabolic stress, contributing to microvascular obstruction and impaired tissue repair. The combined effect is expansion of the infarcted area beyond the initial zone of ischemia. Following infarction, surviving cardiomyocytes undergo metabolic reprogramming. There is a shift toward increased glucose utilization and reduced fatty acid oxidation, resembling a fetal metabolic phenotype. While initially adaptive, this altered metabolism may contribute to long-term inefficiency and heart failure. Scar tissue replaces necrotic myocardium, permanently reducing the heart’s contractile and metabolic capacity.

Conclusion

Myocardial infarction is not merely a vascular event but a complex metabolic collapse within cardiac cells. Oxygen deprivation initiates a cascade of energy failure, mitochondrial dysfunction, ionic imbalance, and oxidative damage that culminates in cell death. Recognizing myocardial infarction as a metabolic catastrophe provides deeper insight into its pathophysiology and opens avenues for metabolic-targeted therapies that may better protect the heart from irreversible injury. Viewing myocardial infarction as a metabolic catastrophe underscores the importance of early intervention aimed at preserving cellular energy balance. Therapeutic strategies that protect mitochondria, reduce oxidative stress, modulate substrate utilization, and stabilize ion homeostasis hold promise in limiting infarct size. Beyond restoring blood flow, preserving intracellular metabolism may be key to improving outcomes.